51 ASTOR PLACE, 10TH FLOOR, NEW YORK, NY
Election of Directors at Adagio Medical Holdings Annual Meeting
Board Expansion and Appointment of Sean Salmon as Director
Reports Third Quarter 2025 Results
Annual Report to Security Holders
Shareholder Director Nominations
Closes Financing of $19 Million Upfront; Positions to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
Announces Pricing of up to Approximately $50 Million Private Placement of Securities
Investor Presentation
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Schedule 13G - Ownership Report
Post-Effective Amendment to Registration Statement